Dispelling myths and removing barriers about insulin in type 2 diabetes

被引:105
作者
Meece, J [1 ]
机构
[1] Plaza Pharm & Wellness Ctr, Gainesville, TX 76240 USA
关键词
D O I
10.1177/0145721705285638
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:9S / 18S
页数:10
相关论文
共 34 条
[31]   Comparison combination of insulin monotherapy and therapy with insulin and insulin and troglitazone in metformin or type 2 diabetes [J].
Strowig, SM ;
Avilés-Santa, ML ;
Raskin, P .
DIABETES CARE, 2002, 25 (10) :1691-1698
[32]   Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) [J].
Turner, RC ;
Holman, RR ;
Cull, CA ;
Stratton, IM ;
Matthews, DR ;
Frighi, V ;
Manley, SE ;
Neil, A ;
McElroy, K ;
Wright, D ;
Kohner, E ;
Fox, C ;
Hadden, D ;
Mehta, Z ;
Smith, A ;
Nugent, Z ;
Peto, R ;
Adlel, AI ;
Mann, JI ;
Bassett, PA ;
Oakes, SF ;
Dornan, TL ;
Aldington, S ;
Lipinski, H ;
Collum, R ;
Harrison, K ;
MacIntyre, C ;
Skinner, S ;
Mortemore, A ;
Nelson, D ;
Cockley, S ;
Levien, S ;
Bodsworth, L ;
Willox, R ;
Biggs, T ;
Dove, S ;
Beattie, E ;
Gradwell, M ;
Staples, S ;
Lam, R ;
Taylor, F ;
Leung, L ;
Carter, RD ;
Brownlee, SM ;
Fisher, KE ;
Islam, K ;
Jelfs, R ;
Williams, PA ;
Williams, FA ;
Sutton, PJ .
LANCET, 1998, 352 (9131) :837-853
[33]   Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart [J].
Vague, P ;
Selam, JL ;
Skeie, S ;
De Leeuw, I ;
Elte, JWF ;
Haahr, H ;
Kristensen, A ;
Draeger, E .
DIABETES CARE, 2003, 26 (03) :590-596
[34]   Sulfonylurea inadequacy - Efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the UK Prospective Diabetes Study (UKPDS 57) [J].
Wright, A ;
Burden, ACF ;
Paisey, RB ;
Cull, CA ;
Holman, RR .
DIABETES CARE, 2002, 25 (02) :330-336